Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations

Rheumatology

Volumn 43, Issue 3, 2004, Pages 358-363

  Vila L M ^a   Alarcon G S ^b   McGwin Jr , G ^c   Friedman, A W ^d   Baethge, B A ^e   Bastian, H M ^b   Fessler, B J ^b   Reveille, J D ^d  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b University of Alabama at Birmingham   (United States)

^c Kentucky   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Activity; Damage; Ethnicity; Hispanics; Systemic lupus erythematosus

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; RO ANTIBODY;

ADULT; AGE; ARTICLE; CENTRAL AMERICA; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ETHNOLOGY; FEMALE; FREQUENCY ANALYSIS; GENDER; GEOGRAPHIC ORIGIN; HISPANIC; HUMAN; IMMUNE SYSTEM; INFLAMMATION; KIDNEY DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEXICO; OUTCOMES RESEARCH; PHOTOSENSITIVITY DISORDER; POISSON DISTRIBUTION; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSIS; PUERTO RICO; RASH; REGRESSION ANALYSIS; SCORING SYSTEM; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TIME; UNITED STATES;

ADULT; AGE FACTORS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; FEMALE; HISPANIC AMERICANS; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PUERTO RICO; REGRESSION ANALYSIS; TEXAS; TREATMENT OUTCOME;

EID: 1542299615     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh048     Document Type: Article

References (38)

1. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994;330: 1871-9.
2. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factor for developing systemic lupus erythematosus. Arthritis Rheum 1998;41: 1714-24.
3. Gaffney PM, Moser KL, Graham RR, Behrens TW. Recent advances in the genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 2002;28:111-26.
4. Ward MM. Examining health disparities in systemic lupus erythematosus. Arthritis Rheum 2001;44:2711-4.
5. Reveille JD, Moulds JM, Ahn C et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA-class II, C4 and CR1 alleles, socioeconomic factors and ethnicity at diseases onset. Arthritis Rheum 1998;41:1161-72.
6. Alarcón GS, Roseman J, Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum 1998;41:1173-80.
7. Alarcón GS, Friedman AW, Straaton KV et al. Systemic lupus erythematosus in three groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus in minority populations: nature vs. nurture. Lupus 1999;8:197-209.
8. Massardo L, Jacobelli S. Occasional series: lupus around the world. The Chilean experience of systemic lupus erythematosus. Lupus 1996;5:175-7.
9. Molina JF, Molina J, Garcia C, Gharavi AE, Wilson WA, Espinoza LR. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus 1997;6:63-7.
10. Vilá LM, Mayor AM, Valentín AH, García-Soberal M, Vilá S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 1999;8:279-86.
11. Gorodezky C, Alaez C, Vázquez-García MN et al. The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 2001;62:979-91.
12. Amaro H, Zambrana RE. Criollo, mestizo, mulato, LatiNegro, indigena, white, or black? The US Hispanic/Latino population and multiple responses in the 2000 census. Am J Public Health 2000; 90:1724-7.
13. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
14. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
15. Liang MH, Fortin PR, Isenberg DA, Snaith L. Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda. Rheumatol Int 1991; 11:133-6.
16. Stoll T, Stucki G, Malik 3, Pyke S, Isenberg DA. Association of the Systemic Lupus Erythematosus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 1997;24:309-13.
17. Alarcón GS, McGwin G, Jr, Bastian HM et al. Systemic lupus erythematosus in three ethnic groups. VII. Predictors of early mortality in the LUMINA cohort. Arthritis Care Res 2001;45: 191-202.
18. Alarcón GS, McGwin G, Jr, Bartolucci AA et al. LUMINA Study Group. Systemic lupus erythematosus in the three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001;44: 2797-806.
19. Calvo-Alén J, Reveille JD, Rodríguez Valverde V et al. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 2003; 12:377-85.
20. Mostoslavsky G, Fischel R, Yachimovich N et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 2001;31:1221-7.
21. Macanovic M, Hogarth MB, Lachmann PJ. Anti-DNA antibodies in the urine of lupus nephritis patients. Nephrol Dial Transplant 1999;14:1418-24.
22. Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology 2001;40:1405-12.
23. Magro CM, Crowson AN. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus. Am J Dermatopathol 1999;21:129-37.
24. Parodi A, Caproni M, Cardinali C et al. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology. Dermatology 2000;200:6-10.
25. Mond CB, Peterson MG, Rothfield NF. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 1989;32:202-4.
26. Martínez-Cruzado JC, Toro-Labrador G, Ho-Fung V et al. Mitocbondrial DNA analysis reveals substantial Native American ancestry in Puerto Rico. Hum Biol 2001;73:491-511.
27. Kinney JP, Long CS. The Ultraviolet Index: a useful tool. Dermatol Online J 2000;6:2.
28. Hasan T, Nyberg F, Stephansson E et al. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol 1997;136:699-705.
29. Vilá LM, Mayor AM, Valentín AH et al. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J 1999;18:89-94.
30. Adler NE, Boyce WT, Chesney MA, Folkman S, Syme SL. Socioeconomic inequalities in health. No easy solution. J Am Med Assoc 1993;269:3140-5.
31. Karlson EW, Daltroy LH, Lew RA et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 1995;2:267-73.
32. Karlson EW, Daltroy LH, Lew RA et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40:47-56.
33. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995;38:274-83.
34. Hulme PA, Rios H. Healthcare reform in Puerto Rico. Managed care in a unique environment. J Nurs Adm 1998;28:44-9.
35. Siegel M, Gwon N, Lee SL, Rivero I, Wong W. Survivorship in systemic lupus erythematosus: Relationship to race and pregnancy. Arthritis Rheum 1969;12:117-25.
36. Siegel M, Holley HL, Lee SL. Epidemiologic studies on SLE. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum 1970;13:802-11.
37. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 1973;3:1-54.
38. López-Acuna D, Hochberg MC, Gihelson AM. Do persons from Spanish heritage have an increased mortality from systemic lupus erythematosus (SLE) compared to other Caucasians? Arthritis Rheum 1982;25:S67.